- Exchange: AktieTorget
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Generic Pharmaceuticals
Eurocine Vaccines AB
+ Add to WatchlistEUCI:SS
6.4500 SEK 0.00000.00%As of 12:00:00 ET on 06/19/2013.
Snapshot for Eurocine Vaccines AB (EUCI)
| Open: | - | Day's Range: | - | Volume: | 2,130 |
|---|---|---|---|---|---|
| Previous Close: | 6.4500 | 52wk Range: | 4.0500 - 21.9000 | 1-Yr Rtn: | -62.72% |
Key Statistics for EUCI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | 2.1572 |
| Relative P/E vs. OMX | - |
| Earnings Per Share (SEK) (ttm) | - |
| Est. EPS (SEK) (06/2013) | 2.9900 |
| Est. PEG Ratio | - |
| Market Cap (M SEK) | 76.75 |
| Shares Outstanding (M) | 11.90 |
| 30 Day Average Volume | 10,449 |
| Price/Book (mrq) | 5.1284 |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/29/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for EUCI
Company Profile & Key Executives for EUCI
Eurocine Vaccines AB develops nasal vaccines for various diseases including influenza and HIV.
| Paer ThuressonChairman | Hans ArwidssonPresident/CEO |
| Jorma HinkulaDirector:Research |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
EUCI News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page